INSM – insmed incorporated (US:NASDAQ)

News

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed To Present at November 2024 Investor Conferences
Insmed Incorporated (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $105.00 price target on the stock, up previously from $100.00.
Insmed's Q3 Loss Wider Than Expected, Sales In Line With Estimates [Yahoo! Finance]
Do You Believe in the Growth Potential of Insmed (INSM)? [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com